secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0000950170-24-070900
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen stockholders approve amended 2023 equity plan, elect directors at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved Amended & Restated 2023 Equity Incentive Plan: 14,014,481 for, 2,868,882 against, 79,455 abstentions (2,335,280 broker non-votes).
- Plan increased authorized shares by 1,200,000 and removed 'liberal' share counting for stock options/SARs.
- Class I directors elected: Elizabeth Mora (8,127,945 for, 8,834,873 withheld) and Heather Rider (10,805,031 for, 6,157,787 withheld).
- Ratification of Deloitte & Touche as auditor for FY2024 approved (19,159,675 for, 135,625 against).
- Advisory vote on executive compensation passed: 15,676,226 for, 1,214,214 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017024070900/0000950170-24-070900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017024070900/ingn-20240605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-070900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer